ferrous sulfate has been researched along with teferrol in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.81) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 12 (44.44) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Geisser, P; Müller, A | 2 |
| Jacobs, P | 1 |
| Kaltwasser, JP; Niechzial, M; Werner, E | 1 |
| Fischer, R; Gabbe, EE; Heinrich, HC; Nielsen, P | 1 |
| Coghlan, P; Fransman, D; Jacobs, P | 1 |
| Campbell, SB; Gissane, R; Hawley, CM; Herzig, KA; Isbel, NM; Johnson, DW | 1 |
| Berge, RK; Berstad, A; Erichsen, K; Grimstad, T; Hausken, T; Ulvik, RJ | 1 |
| Gopalan, S; Malhotra, S; Pandhi, P; Saha, L; Saha, PK | 1 |
| Johnson, DW | 1 |
| Brignoli, R; Toblli, JE | 1 |
| Angerosa, M; Cao, G; Olivieri, L; Toblli, JE | 1 |
| Bopche, AV; Dwivedi, R; Mishra, R; Patel, GS | 1 |
| Ball, MJ; Bates, G; Bates, J; Brain, T; Dennis, A; Khalafallah, A; Rasko, JE; Robertson, IK; Seaton, D; Smith, L | 1 |
| Fallon, K; Garvican, LA; Gore, CJ; Lobigs, L; Telford, R | 1 |
| Breymann, C; Frer, C; Macagno, E; Monterrosa, B; Ortiz, R; Romero, JD; Toblli, JE | 1 |
| Arriaga, C; Orozco, MN; Schümann, K; Solomons, NW | 1 |
| Marx, J; Orozco, M; Romero-Abal, ME; Schümann, K; Solomons, NW; Weiss, G | 1 |
| Angerosa, M; Cao, G; Oliveri, L; Toblli, JE | 1 |
| Aycicek, A; Guzel, B; Kaya, C; Koc, A; Oymak, Y; Selek, S | 1 |
| Orozco, M; Romero-Abal, ME; Schümann, K; Solomons, NW; Weiss, G | 1 |
| Angerosa, M; Cao, G; Toblli, JE | 1 |
| Cetin, M; Gumruk, F; Ozsurekci, Y; Unal, S | 1 |
| Arvas, A; Aydin, A; Can, G; Erener-Ercan, T; Gur, E | 1 |
| Allen, JC; Chuang, A; Dennis, A; Falloon, P; Gray, Z; Hanna, F; Hyppa, A; Khalafallah, AA; Kwok, C; Mathew, R; Pavlov, T; Wilson, E; Yan, C | 1 |
| Chavan, S; Rana, P; Tekur, U; Tripathi, R | 1 |
| Arulparithi, CS; Arunbabu, T; Manjani, S | 1 |
3 review(s) available for ferrous sulfate and teferrol
| Article | Year |
|---|---|
Intravenous versus oral iron supplementation in peritoneal dialysis patients.
Topics: Administration, Oral; Clinical Trials as Topic; Darbepoetin alfa; Erythropoietin; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Peritoneal Dialysis; Recombinant Proteins; Transferrin | 2007 |
Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis.
Topics: Adult; Anemia, Iron-Deficiency; Dietary Supplements; Endpoint Determination; Ferric Compounds; Ferrous Compounds; Humans; Randomized Controlled Trials as Topic; Risk Assessment | 2007 |
Iron Preparations in the Management of Iron Deficiency Anemia in Infants and Children: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Ferritins; Hemoglobins; Humans; Infant; Iron; Iron Compounds | 2023 |
13 trial(s) available for ferrous sulfate and teferrol
| Article | Year |
|---|---|
Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
Topics: Adult; Anemia, Hypochromic; Ascorbic Acid; Biological Availability; Ferric Compounds; Ferrous Compounds; Food; Humans; Intestinal Absorption; Iron; Iron Radioisotopes; Male | 1987 |
Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors.
Topics: Anemia, Hypochromic; Biological Availability; Blood Donors; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Iron; Male; Prospective Studies | 1993 |
Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Antioxidants; Biomarkers; Dinoprost; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Iron Deficiencies; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Tablets; Vasoconstrictor Agents | 2005 |
Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.
Topics: Adult; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Double-Blind Method; Female; Ferric Compounds; Ferrous Compounds; Humans; Pregnancy; Pregnancy Complications, Hematologic | 2007 |
Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
Topics: Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferrous Compounds; Hemoglobins; Humans; Infant; Male | 2009 |
A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Birth Weight; Drug Therapy, Combination; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Infant, Newborn; Infusions, Intravenous; Patient Compliance; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Quality of Life; Young Adult | 2010 |
Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.
Topics: Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Gestational Age; Hematocrit; Hemoglobins; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome | 2011 |
Equivalent effects on fecal reactive oxygen species generation with oral supplementation of three iron compounds: ferrous sulfate, sodium iron EDTA and iron polymaltose.
Topics: Adolescent; Adult; Antioxidants; Dietary Supplements; Edetic Acid; Feces; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Iron; Iron, Dietary; Male; Middle Aged; Oxidants; Oxidative Stress; Reactive Oxygen Species; Young Adult | 2012 |
Oral administration of ferrous sulfate, but not of iron polymaltose or sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), results in a substantial increase of non-transferrin-bound iron in healthy iron-adequate men.
Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Dietary Supplements; Edetic Acid; Endemic Diseases; Ferric Compounds; Ferrous Compounds; Food, Fortified; Guatemala; Hemoglobins; Humans; Iron; Kinetics; Malaria, Falciparum; Male; Middle Aged; Risk; Young Adult | 2012 |
Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia.
Topics: Anemia, Iron-Deficiency; Antioxidants; Child; Child, Preschool; Delayed-Action Preparations; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Male; Oxidants; Oxidation-Reduction; Oxidative Stress; Treatment Outcome | 2014 |
Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Infant; Male; Treatment Outcome; Zinc | 2019 |
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Humans; Infusions, Intravenous; Maltose; Middle Aged; Pregnancy; Prospective Studies; Young Adult | 2018 |
Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Ascorbic Acid; Child; Female; Ferric Compounds; Ferrous Compounds; Humans; Pregnancy; Pregnant Women; Young Adult | 2021 |
11 other study(ies) available for ferrous sulfate and teferrol
| Article | Year |
|---|---|
Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes.
Topics: Anemia; Animals; Ferric Compounds; Ferrous Compounds; Intestinal Absorption; Iron; Kinetics; Male; Models, Biological; Rats | 1987 |
Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
Topics: Animals; Ascorbic Acid; Biological Availability; Ferric Compounds; Ferrous Compounds; Humans; In Vitro Techniques; Intestinal Absorption; Iron; Iron Deficiencies; Male; Rats | 1987 |
Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
Topics: Administration, Oral; Anemia, Hypochromic; Animals; Female; Ferric Compounds; Ferrous Compounds; Injections, Intravenous; Intestinal Absorption; Iron; Kinetics; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1984 |
Bioavailability of iron from oral ferric polymaltose in humans.
Topics: Administration, Oral; Adult; Anemia, Hypochromic; Biological Availability; Ferric Compounds; Ferrous Compounds; Hematinics; Hemorrhage; Humans; Hydrogen-Ion Concentration; Iron; Iron Radioisotopes; Neutron Activation Analysis | 1994 |
Oral versus intravenous iron supplementation in peritoneal dialysis patients.
Topics: Administration, Oral; Erythropoietin; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Peritoneal Dialysis; Recombinant Proteins; Transferrin | 2001 |
Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Gastrointestinal Diseases; Intestinal Mucosa; Iron Chelating Agents; Lethal Dose 50; Liver Function Tests; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Time Factors; Toxicity Tests, Acute | 2008 |
Haemoglobin mass in an anaemic female endurance runner before and after iron supplementation.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Biomarkers; Breath Tests; Drug Administration Schedule; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intramuscular; Physical Endurance; Running; Time Factors; Treatment Outcome; Young Adult | 2011 |
Effects of iron polymaltose complex, ferrous fumarate and ferrous sulfate treatments in anemic pregnant rats, their fetuses and placentas.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Disease Models, Animal; Female; Ferric Compounds; Ferrous Compounds; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Interleukin-6; Oxidative Stress; Placenta; Pregnancy; Pregnancy Outcome; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2013 |
Differences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores.
Topics: Adult; Dietary Supplements; Edetic Acid; Female; Ferric Compounds; Ferrous Compounds; Guatemala; Humans; Iron; Iron Deficiencies; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Transferrin | 2013 |
Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
Topics: Administration, Oral; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2015 |
Comparison of Different Iron Preparations in the Prophylaxis of Iron-deficiency Anemia.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infant; Premedication; Treatment Outcome | 2017 |